^
    over1year
    To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer (clinicaltrials.gov)
    P2, N=10, Terminated, SynCore Biotechnology Co., Ltd. | N=37 --> 10
    Enrollment change • Metastases
    |
    SB01
    over1year
    To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer (clinicaltrials.gov)
    P2, N=37, Terminated, SynCore Biotechnology Co., Ltd. | N=10 --> 37
    Enrollment change • Metastases
    |
    SB01